Coeckelenbergh, Sean
Soucy-Proulx, Maxim
Van der Linden, Philippe
Clanet, Matthieu
Rinehart, Joseph
Cannesson, Maxime
Duranteau, Jacques
Joosten, Alexandre
Article History
Received: 18 September 2023
Accepted: 6 November 2023
First Online: 18 December 2023
Declarations
:
: Alexandre Joosten, Maxime Cannesson, and Joseph Rinehart are consultants for Edwards Lifesciences, USA. They have ownership interest in Sironis, and Sironis has developed the closed-loop vasopressor system used in this study. Sironis provided no direct or indirect funding in support of the current work, to the individual authors, or any of their respective departments. The other authors have no conflicts of interest concerning this study.
: This study was approved on August 24th, 2020, by the Comité de Protection des Personnes Sud-Est I (2020-A01149-30) and registered prior to patient enrollment on clinicaltrials.gov (NCT04639037: November 20th, 2020).